Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,908 | -6,248 | -4,154 | -2,119 | -7,360 |
| Depreciation Amortization | 67 | 51 | 36 | 18 | 81 |
| Accounts payable and accrued liabilities | 259 | 306 | 186 | 171 | 39 |
| Other Working Capital | -213 | -253 | -267 | -262 | -523 |
| Other Operating Activity | 150 | 45 | 91 | 17 | 243 |
| Operating Cash Flow | $-8,645 | $-6,099 | $-4,108 | $-2,175 | $-7,520 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -77 | -16 | -1 | -5 |
| Investing Cash Flow | $-72 | $-77 | $-16 | $-1 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 781 | 61 | 61 | 43 | 18,823 |
| Other Financing Activity | -3 | -55 | 0 | 0 | 0 |
| Financing Cash Flow | $772 | $6 | $61 | $43 | $18,823 |
| Beginning Cash Position | 14,929 | 14,929 | 14,929 | 14,929 | 3,631 |
| End Cash Position | 6,984 | 8,759 | 10,866 | 12,796 | 14,929 |
| Net Cash Flow | $-7,945 | $-6,170 | $-4,063 | $-2,133 | $11,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,645 | -6,099 | -4,108 | -2,175 | -7,520 |
| Capital Expenditure | -72 | -77 | -16 | -1 | -5 |
| Free Cash Flow | -8,717 | -6,176 | -4,124 | -2,176 | -7,525 |